CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
Northwestern Mutual’s A.I. and money report shows that consumers want their adviser to take advantage of ‘superpowers’ granted by artificial intelligence tools.
The FDRA is a trade association that supports nearly 500 brands worldwide including Nike, Adidas, Walmart, and Target and represents over 90% of US shoe sales.
Lead Analyst at TVREV, Alan Wolk, joins Cheddar to discuss the latest in media and business news, including why business at the box office may be slowing down.
